Selected research
Industry Growth & Trends
Global Prenatal Genetic Screening Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Prenatal Genetic Screening Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Prenatal Genetic Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Prenatal Genetic Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prenatal Genetic Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Prenatal Genetic Screening Services market include ACOG, Penn Medicine, Yale New Haven Health, Yale Medicine, PCRM Vancouver Fertility Clinic, Natera, VCGS, Genome Medical and Henry Ford Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Prenatal Genetic Screening Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Prenatal Genetic Screening Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prenatal Genetic Screening Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prenatal Genetic Screening Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Prenatal Genetic Screening Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Prenatal Genetic Screening Services Market by Company
ACOG
Penn Medicine
Yale New Haven Health
Yale Medicine
PCRM Vancouver Fertility Clinic
Natera
VCGS
Genome Medical
Henry Ford Health
Advocate Health Care
NJ Perinatal Associates
CENTOGENE
Lehigh Valley Health Network (LVHN)
Genetics.ie
Insight Medical Genetics
The Royal Women's Hospital
Stanford Medicine Children's Health
UCHealth
Atlantic Health System
Children's Hospital Colorado
Prenatal Genetic Screening Services Segment by Type
Prenatal Screening Tests
Prenatal Diagnostic Tests
Prenatal Genetic Screening Services Segment by Application
First-trimester
Second-trimester
Prenatal Genetic Screening Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Genetic Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prenatal Genetic Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Genetic Screening Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Prenatal Genetic Screening Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Prenatal Screening Tests
- Prenatal Diagnostic Tests
Applications
- First-trimester
- Second-trimester
Companies covered
- ACOG
- Penn Medicine
- Yale New Haven Health
- Yale Medicine
- PCRM Vancouver Fertility Clinic
- Natera
- VCGS
- Genome Medical
- Henry Ford Health
- Advocate Health Care
- NJ Perinatal Associates
- CENTOGENE
- Lehigh Valley Health Network (LVHN)
- Genetics.ie
- Insight Medical Genetics
- The Royal Women's Hospital
- Stanford Medicine Children's Health
- UCHealth
- Atlantic Health System
- Children's Hospital Colorado
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Prenatal Genetic Screening Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Prenatal Genetic Screening Services Market Size by Region (2021-2032)
- 1.4.1 Global Prenatal Genetic Screening Services Market Size by Region (2021-2026)
- 1.4.2 Global Prenatal Genetic Screening Services Market Size by Region (2027-2032)
- 1.5 Key Regions Prenatal Genetic Screening Services Market Size (2021-2032)
- 1.5.1 North America Prenatal Genetic Screening Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Prenatal Genetic Screening Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Prenatal Genetic Screening Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Prenatal Genetic Screening Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Prenatal Genetic Screening Services Market Size Growth Rate (2021-2032)
2 Prenatal Genetic Screening Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Prenatal Screening Tests
- 2.1.2 Prenatal Diagnostic Tests
- 2.2 Global Prenatal Genetic Screening Services Market Size by Type
- 2.2.1 Global Prenatal Genetic Screening Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Prenatal Genetic Screening Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Prenatal Genetic Screening Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Prenatal Genetic Screening Services Market Size by Regions
- 2.3.1 North America Prenatal Genetic Screening Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Prenatal Genetic Screening Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Prenatal Genetic Screening Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Prenatal Genetic Screening Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Prenatal Genetic Screening Services Market Size Breakdown by Type (2021-2026)
3 Prenatal Genetic Screening Services Market by Application
- 3.1 Type Introduction
- 3.1.1 First-trimester
- 3.1.2 Second-trimester
- 3.2 Global Prenatal Genetic Screening Services Market Size by Application
- 3.2.1 Global Prenatal Genetic Screening Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Prenatal Genetic Screening Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Prenatal Genetic Screening Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Prenatal Genetic Screening Services Market Size by Regions
- 3.3.1 North America Prenatal Genetic Screening Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Prenatal Genetic Screening Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Prenatal Genetic Screening Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Prenatal Genetic Screening Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Prenatal Genetic Screening Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Prenatal Genetic Screening Services Industry Trends
- 4.2 Prenatal Genetic Screening Services Industry Drivers
- 4.3 Prenatal Genetic Screening Services Industry Opportunities and Challenges
- 4.4 Prenatal Genetic Screening Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Prenatal Genetic Screening Services Revenue (2021-2026)
- 5.2 Global Prenatal Genetic Screening Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Prenatal Genetic Screening Services Key Company Headquarters & Area Served
- 5.4 Global Prenatal Genetic Screening Services Company, Product Type & Application
- 5.5 Global Prenatal Genetic Screening Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Prenatal Genetic Screening Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Prenatal Genetic Screening Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Prenatal Genetic Screening Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ACOG
- 6.1.1 ACOG Company Information
- 6.1.2 ACOG Business Overview
- 6.1.3 ACOG Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ACOG Prenatal Genetic Screening Services Product Portfolio
- 6.1.5 ACOG Recent Developments
- 6.2 Penn Medicine
- 6.2.1 Penn Medicine Company Information
- 6.2.2 Penn Medicine Business Overview
- 6.2.3 Penn Medicine Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Penn Medicine Prenatal Genetic Screening Services Product Portfolio
- 6.2.5 Penn Medicine Recent Developments
- 6.3 Yale New Haven Health
- 6.3.1 Yale New Haven Health Company Information
- 6.3.2 Yale New Haven Health Business Overview
- 6.3.3 Yale New Haven Health Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Yale New Haven Health Prenatal Genetic Screening Services Product Portfolio
- 6.3.5 Yale New Haven Health Recent Developments
- 6.4 Yale Medicine
- 6.4.1 Yale Medicine Company Information
- 6.4.2 Yale Medicine Business Overview
- 6.4.3 Yale Medicine Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Yale Medicine Prenatal Genetic Screening Services Product Portfolio
- 6.4.5 Yale Medicine Recent Developments
- 6.5 PCRM Vancouver Fertility Clinic
- 6.5.1 PCRM Vancouver Fertility Clinic Company Information
- 6.5.2 PCRM Vancouver Fertility Clinic Business Overview
- 6.5.3 PCRM Vancouver Fertility Clinic Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 PCRM Vancouver Fertility Clinic Prenatal Genetic Screening Services Product Portfolio
- 6.5.5 PCRM Vancouver Fertility Clinic Recent Developments
- 6.6 Natera
- 6.6.1 Natera Company Information
- 6.6.2 Natera Business Overview
- 6.6.3 Natera Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Natera Prenatal Genetic Screening Services Product Portfolio
- 6.6.5 Natera Recent Developments
- 6.7 VCGS
- 6.7.1 VCGS Company Information
- 6.7.2 VCGS Business Overview
- 6.7.3 VCGS Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 VCGS Prenatal Genetic Screening Services Product Portfolio
- 6.7.5 VCGS Recent Developments
- 6.8 Genome Medical
- 6.8.1 Genome Medical Company Information
- 6.8.2 Genome Medical Business Overview
- 6.8.3 Genome Medical Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Genome Medical Prenatal Genetic Screening Services Product Portfolio
- 6.8.5 Genome Medical Recent Developments
- 6.9 Henry Ford Health
- 6.9.1 Henry Ford Health Company Information
- 6.9.2 Henry Ford Health Business Overview
- 6.9.3 Henry Ford Health Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Henry Ford Health Prenatal Genetic Screening Services Product Portfolio
- 6.9.5 Henry Ford Health Recent Developments
- 6.10 Advocate Health Care
- 6.10.1 Advocate Health Care Company Information
- 6.10.2 Advocate Health Care Business Overview
- 6.10.3 Advocate Health Care Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Advocate Health Care Prenatal Genetic Screening Services Product Portfolio
- 6.10.5 Advocate Health Care Recent Developments
- 6.11 NJ Perinatal Associates
- 6.11.1 NJ Perinatal Associates Company Information
- 6.11.2 NJ Perinatal Associates Business Overview
- 6.11.3 NJ Perinatal Associates Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 NJ Perinatal Associates Prenatal Genetic Screening Services Product Portfolio
- 6.11.5 NJ Perinatal Associates Recent Developments
- 6.12 CENTOGENE
- 6.12.1 CENTOGENE Company Information
- 6.12.2 CENTOGENE Business Overview
- 6.12.3 CENTOGENE Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 CENTOGENE Prenatal Genetic Screening Services Product Portfolio
- 6.12.5 CENTOGENE Recent Developments
- 6.13 Lehigh Valley Health Network (LVHN)
- 6.13.1 Lehigh Valley Health Network (LVHN) Company Information
- 6.13.2 Lehigh Valley Health Network (LVHN) Business Overview
- 6.13.3 Lehigh Valley Health Network (LVHN) Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Lehigh Valley Health Network (LVHN) Prenatal Genetic Screening Services Product Portfolio
- 6.13.5 Lehigh Valley Health Network (LVHN) Recent Developments
- 6.14 Genetics.ie
- 6.14.1 Genetics.ie Company Information
- 6.14.2 Genetics.ie Business Overview
- 6.14.3 Genetics.ie Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Genetics.ie Prenatal Genetic Screening Services Product Portfolio
- 6.14.5 Genetics.ie Recent Developments
- 6.15 Insight Medical Genetics
- 6.15.1 Insight Medical Genetics Company Information
- 6.15.2 Insight Medical Genetics Business Overview
- 6.15.3 Insight Medical Genetics Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Insight Medical Genetics Prenatal Genetic Screening Services Product Portfolio
- 6.15.5 Insight Medical Genetics Recent Developments
- 6.16 The Royal Women's Hospital
- 6.16.1 The Royal Women's Hospital Company Information
- 6.16.2 The Royal Women's Hospital Business Overview
- 6.16.3 The Royal Women's Hospital Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 The Royal Women's Hospital Prenatal Genetic Screening Services Product Portfolio
- 6.16.5 The Royal Women's Hospital Recent Developments
- 6.17 Stanford Medicine Children's Health
- 6.17.1 Stanford Medicine Children's Health Company Information
- 6.17.2 Stanford Medicine Children's Health Business Overview
- 6.17.3 Stanford Medicine Children's Health Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Stanford Medicine Children's Health Prenatal Genetic Screening Services Product Portfolio
- 6.17.5 Stanford Medicine Children's Health Recent Developments
- 6.18 UCHealth
- 6.18.1 UCHealth Company Information
- 6.18.2 UCHealth Business Overview
- 6.18.3 UCHealth Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 UCHealth Prenatal Genetic Screening Services Product Portfolio
- 6.18.5 UCHealth Recent Developments
- 6.19 Atlantic Health System
- 6.19.1 Atlantic Health System Company Information
- 6.19.2 Atlantic Health System Business Overview
- 6.19.3 Atlantic Health System Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Atlantic Health System Prenatal Genetic Screening Services Product Portfolio
- 6.19.5 Atlantic Health System Recent Developments
- 6.20 Children's Hospital Colorado
- 6.20.1 Children's Hospital Colorado Company Information
- 6.20.2 Children's Hospital Colorado Business Overview
- 6.20.3 Children's Hospital Colorado Prenatal Genetic Screening Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Children's Hospital Colorado Prenatal Genetic Screening Services Product Portfolio
- 6.20.5 Children's Hospital Colorado Recent Developments
7 North America
- 7.1 North America Prenatal Genetic Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 7.3 North America Prenatal Genetic Screening Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Prenatal Genetic Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 8.3 Europe Prenatal Genetic Screening Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Prenatal Genetic Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Prenatal Genetic Screening Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Prenatal Genetic Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 10.3 South America Prenatal Genetic Screening Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Prenatal Genetic Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Prenatal Genetic Screening Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst